| Category | Amount |
|---|---|
| N/A |
| Description of Property | Date Acquired | Cost or Other Basis | Prior Years' Depreciation | Computation Method | Rate / Life (# of years) |
Current Year's Depreciation Expense | Net Investment Income | Adjusted Net Income | Cost of Goods Sold Not Included |
|---|
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| FIDELITY 500 INDEX SHARES | AT COST | 34,898 | 86,377 |
| JPMORGAN CHASE & CO | AT COST | 18,799 | 69,929 |
| QVT FAMILY OFFICE OFFSHORE LTD | AT COST | 100,000 | 160,427 |
| CYMABAY THERAPEUTICS | AT COST | 40,000 | 45,920 |
| QVT SLV SHARES | AT COST | 52,766 | 44,044 |
| FIDELITY MMKT PREMIUM CLASS | AT COST | 5,653 | 5,653 |
| VANGUARD INDEX FDS | AT COST | 38,158 | 66,332 |
| ROCKET PHARMACEUTICALS INC | AT COST | 4,474 | 93,228 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| CASH IN TRANSIT | 0 | 9,951 | 9,951 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| OTHER PROFESSIONAL FEES | 160 | 160 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| US TREASURY | 135 | 135 |